Stay updated on Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Sign up to get notified when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.

Latest updates to the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page
- Check7 days agoChange DetectedLocations section was updated with changes across many regions, including additions and removals of sites worldwide. The page's location data now reflects current trial sites and availability.SummaryDifference2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision changed from v3.3.1 to v3.3.2; this is a metadata update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedPublication source wording was clarified to indicate that publications are automatically filled from PubMed and the revision version was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedThe study location entry changed from 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 736'.SummaryDifference0.1%

- Check58 days agoChange DetectedTwo screenshots show essentially identical page content and layout; no additions or deletions detected in the study details page.SummaryDifference0.2%

- Check79 days agoChange DetectedRegional rebranding: 'Rhône-Alpes' locations are replaced with 'Auvergne-Rhône-Alpes' equivalents, updating the area qualifier for the listed towns.SummaryDifference4%

Stay in the know with updates to Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.